Streetbeat News

Stock Prices

AVTX

Avalo Therapeutics has announced a 1-for-240 reverse stock split of its common stock. The split-adjusted trading on the Nasdaq Capital Market will begin on December 29, 2023, under the existing symbol 'AVTX'. This action will decrease the outstanding shares from roughly 192.4 million to approximately 801,611.

Portfolio Pulse from Benzinga Newsdesk

December 27, 2023 | 12:03 pm

EXPE

Expedia Group (NASDAQ:EXPE) received mixed analyst ratings over the past three months, with 7 analysts offering their perspectives. The average 12-month price target for EXPE has increased to $155.0, up from $130.43, with a high estimate of $200.00 and a low of $115.00. Analysts from firms including BTIG, Barclays, Oppenheimer, Evercore ISI Group, Morgan Stanley, Piper Sandler, and Wedbush have raised their price targets for EXPE. The company's financials show a market capitalization above industry average, a revenue growth rate of 8.57% as of September 30, 2023, but lagging net margin, ROE, and ROA compared to industry averages, and a debt-to-equity ratio of 3.91.

Portfolio Pulse from Benzinga Insights

December 27, 2023 | 12:00 pm

CNXA

CZOO

UCAR

The article highlights three consumer discretionary stocks that are currently oversold according to their Relative Strength Index (RSI) values, suggesting they may be undervalued. Connexa Sports Technologies Inc. (CNXA) reported a Q2 loss but expects revenue growth and profitability in Q4 of fiscal 2024. U Power Limited (UCAR) announced a follow-on offering, and Cazoo Group Ltd (CZOO) completed debt restructuring. All three stocks have seen significant price drops over the past month.

Portfolio Pulse from Avi Kapoor

December 27, 2023 | 11:56 am

ELTX

HPK

KRP

The article reports on notable insider purchases of shares in three companies, suggesting confidence in their future prospects. Elicio Therapeutics, Inc. (ELTX) saw a 10% owner acquire over 1.2 million shares. Kimbell Royalty Partners, LP (KRP) had a director purchase 30,000 shares. HighPeak Energy, Inc. (HPK) CEO bought 150,442 shares. Insider buying can be a positive signal for investors, but should not be the sole basis for investment decisions.

Portfolio Pulse from Avi Kapoor

December 27, 2023 | 11:56 am

BTCUSD

GOOGL

Artificial intelligence (AI) has surpassed 'Bitcoin' and 'Crypto' as the most searched term on Google in 2023, with a significant increase in interest following the launch of OpenAI's ChatGPT. Despite Bitcoin's price recovery in 2023, it still deals with the aftermath of the 2022 bear market. The rise in AI searches also extends to job-related queries, with 'AI jobs' searches outpacing 'crypto jobs'. This trend reflects AI's growing prominence in daily life and may indicate a shift in public interest from cryptocurrencies to AI technology.

Portfolio Pulse from Benzinga Neuro

December 27, 2023 | 11:55 am

EXPE

BTIG analyst Jake Fuller has reaffirmed a Buy rating on Expedia Group (NASDAQ:EXPE) and increased the price target from $150 to $175, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 27, 2023 | 11:54 am

FSR

Fisker Inc. (NYSE:FSR), an electric vehicle manufacturer, has announced the delivery of its first Fisker Ocean Sport electric SUV to a customer. The hand-over took place at the Fisker Lounge London location within the Westfield London mall.

Portfolio Pulse from Benzinga Newsdesk

December 27, 2023 | 11:32 am

ALT

BITF

BTBT

BUR

CHRS

CIFR

HIVE

WULF

Coherus BioSciences, Inc. (NASDAQ:CHRS) shares surged 34.8% in pre-market trading after the FDA approved UDENYCA ONBODY for pegfilgrastim-cbqv. Other stocks showing pre-market gains include Burford Capital Limited (NYSE:BUR), TeraWulf Inc. (NASDAQ:WULF), Bitfarms Ltd. (NASDAQ:BITF), Bit Digital, Inc. (NASDAQ:BTBT), HIVE Digital Technologies Ltd. (NASDAQ:HIVE), Cipher Mining Inc. (NASDAQ:CIFR), and Altimmune, Inc. (NASDAQ:ALT). U.S. stock futures were slightly lower, with Dow Jones futures down about 5 points.

Portfolio Pulse from Avi Kapoor

December 27, 2023 | 11:08 am

BMWYY

BYDDY

MBGAF

BYD Company has received a conditional testing license for Level 3 autonomous driving on high-speed roads in China, marking progress in the EV maker's autonomous technology. This is the first such license granted in China since BYD's initial award in July. The development reflects the increasing competition among automakers in China's autonomous driving space, with BMW and Mercedes Benz also pursuing similar advancements. BYD's stock (OTC:BYDDY) closed higher by 1.27% at $53.38 following the news.

Portfolio Pulse from Shivani Kumaresan

December 27, 2023 | 10:57 am

RIVN

A Rivian Automotive Inc (RIVN) R1T owner has been waiting for eight months for repairs after an accident. The delay was due to a specialized diagnostic software requirement and further damage during the repair process. Despite this, Rivian delivered 15,564 vehicles in Q3 and reported a revenue of $1.337 billion, with a loss of $1.19 per share, beating estimates. The company aims for a positive gross profit by 2024 and is developing its R2 platform.

Portfolio Pulse from Anan Ashraf

December 27, 2023 | 10:13 am